4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-24-012167
Options or other derivatives
- Chief Medical Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ciulla Thomas Chief Medical Officer | 2024-02-05 | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | D | ||
Loading xslF345X05/ownership.xml…